Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) is advised as a treatment option for epithelial ovarian cancer (EOC) with peritoneal carcinomatosis. This study was designed to define the pharmacokinetics of cisplatin (CDDP) and paclitaxel (PTX) administered together during HIPEC. METHO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Ansaloni, L, Coccolini, F, Morosi, L, Ballerini, A, Ceresoli, M, Grosso, G, Bertoli, P, Busci, L M, Lotti, M, Cambria, F, Pisano, M, Rossetti, D, Frigerio, L, D'Incalci, M, Zucchetti, M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453456/
https://ncbi.nlm.nih.gov/pubmed/25461804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.602
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars